CYP2C19
E567681
CYP2C19 is a liver enzyme of the cytochrome P450 family that plays a key role in the metabolism of various drugs, including certain antidepressants, proton pump inhibitors, and antiplatelet agents.
All labels observed (1)
| Label | Occurrences |
|---|---|
| CYP2C19 canonical | 3 |
How this entity was disambiguated
This entity first appeared as the object of triple T6064967 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: CYP2C19 Context triple: [Prozac, isMetabolizedBy, CYP2C19]
-
A.
CYP2C9
CYP2C9 is a liver enzyme of the cytochrome P450 family that plays a key role in metabolizing various drugs, including many nonsteroidal anti-inflammatory agents and anticoagulants.
-
B.
CYP2D6
CYP2D6 is a highly polymorphic cytochrome P450 enzyme that plays a major role in the metabolism of many drugs, contributing significantly to interindividual variability in drug response.
-
C.
CYP1A2
CYP1A2 is a liver enzyme of the cytochrome P450 family that plays a key role in the metabolism of various drugs and xenobiotics.
-
D.
CYP3A4
CYP3A4 is a major human liver and intestinal enzyme of the cytochrome P450 family responsible for metabolizing a wide range of drugs and xenobiotics.
-
E.
CYP2J2
CYP2J2 is a human cytochrome P450 enzyme primarily expressed in the heart and other tissues, involved in the metabolism of various drugs and endogenous fatty acids.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: CYP2C19 Target entity description: CYP2C19 is a liver enzyme of the cytochrome P450 family that plays a key role in the metabolism of various drugs, including certain antidepressants, proton pump inhibitors, and antiplatelet agents.
-
A.
CYP2C9
CYP2C9 is a liver enzyme of the cytochrome P450 family that plays a key role in metabolizing various drugs, including many nonsteroidal anti-inflammatory agents and anticoagulants.
-
B.
CYP2D6
CYP2D6 is a highly polymorphic cytochrome P450 enzyme that plays a major role in the metabolism of many drugs, contributing significantly to interindividual variability in drug response.
-
C.
CYP1A2
CYP1A2 is a liver enzyme of the cytochrome P450 family that plays a key role in the metabolism of various drugs and xenobiotics.
-
D.
CYP3A4
CYP3A4 is a major human liver and intestinal enzyme of the cytochrome P450 family responsible for metabolizing a wide range of drugs and xenobiotics.
-
E.
CYP2J2
CYP2J2 is a human cytochrome P450 enzyme primarily expressed in the heart and other tissues, involved in the metabolism of various drugs and endogenous fatty acids.
- F. None of above. chosen
Statements (50)
| Predicate | Object |
|---|---|
| instanceOf |
cytochrome P450 enzyme
ⓘ
drug-metabolizing enzyme ⓘ enzyme ⓘ protein-coding gene product ⓘ |
| affects |
plasma concentration of certain antidepressants
ⓘ
plasma concentration of proton pump inhibitors ⓘ response to clopidogrel ⓘ |
| belongsToFamily | cytochrome P450 family 2 ⓘ |
| belongsToSubfamily | cytochrome P450 subfamily C NERFINISHED ⓘ |
| clinicalRelevance |
dose adjustment of certain antidepressants
ⓘ
dose adjustment of proton pump inhibitors ⓘ personalized medicine ⓘ pharmacogenomics ⓘ |
| encodedBy | CYP2C19 gene ⓘ |
| fullName | cytochrome P450 family 2 subfamily C member 19 NERFINISHED ⓘ |
| hasFunction |
drug metabolism
ⓘ
oxidation of xenobiotics ⓘ xenobiotic metabolism ⓘ |
| hasMolecularFunction |
monooxygenase activity
ⓘ
oxidoreductase activity ⓘ |
| hasPolymorphism |
CYP2C19*1
ⓘ
CYP2C19*17 NERFINISHED ⓘ CYP2C19*2 NERFINISHED ⓘ CYP2C19*3 NERFINISHED ⓘ |
| highExpressionSite | liver ⓘ |
| inhibitedBy |
fluvoxamine
ⓘ
omeprazole NERFINISHED ⓘ |
| isKeyFor | bioactivation of clopidogrel ⓘ |
| locatedIn | endoplasmic reticulum ⓘ |
| metabolizes |
amitriptyline
ⓘ
citalopram NERFINISHED ⓘ clopidogrel ⓘ diazepam ⓘ escitalopram ⓘ imipramine ⓘ lansoprazole ⓘ mephenytoin NERFINISHED ⓘ omeprazole NERFINISHED ⓘ pantoprazole ⓘ phenytoin ⓘ proguanil ⓘ voriconazole ⓘ |
| organism | Homo sapiens NERFINISHED ⓘ |
| pathway | phase I drug metabolism ⓘ |
| usesCofactor |
NADPH
ⓘ
heme ⓘ |
| variationConsequence |
extensive metabolizer phenotype
ⓘ
intermediate metabolizer phenotype ⓘ poor metabolizer phenotype ⓘ ultrarapid metabolizer phenotype ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: CYP2C19 Description of subject: CYP2C19 is a liver enzyme of the cytochrome P450 family that plays a key role in the metabolism of various drugs, including certain antidepressants, proton pump inhibitors, and antiplatelet agents.
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.